Connect with others who understand.

Sign up Log in
Resources
About MyMyelomaTeam
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Allogeneic (donor) Stem Cell Transplant

A MyMyelomaTeam Member asked a question 💭
San Jose, CA

what is the difference between myeloma and multiple myeloma or are they
the same thing?
Thanks,
Fern

July 15, 2024
Be the first to like/hug
A MyMyelomaTeam Member

Myeloma is the same as multiple myeloma

July 15, 2024
MyMyelomaTeam

Here is detailed information about allogeneic (donor) stem cell transplants for myeloma based on the knowledge base:

Overview
- Purpose: Replace cancerous bone marrow cells with healthy stem cells
- Common Use: Less common than autologous transplants, typically considered for younger people with relapsed, high-risk Show Full Answer

Here is detailed information about allogeneic (donor) stem cell transplants for myeloma based on the knowledge base:

Overview
- Purpose: Replace cancerous bone marrow cells with healthy stem cells.
- Common Use: Less common than autologous transplants, typically considered for younger people with relapsed, high-risk myeloma.

Process
- Preparation:
- Chemotherapy, radiation, or both are administered to destroy cancerous cells.
- Stem Cell Source:
- Donor, often a close blood relative or a good genetic match.
- Stem cells are usually harvested from the blood (peripheral blood stem cells) rather than bone marrow.

Benefits
- Graft-Versus-Myeloma Effect:
- Donated immune cells may attack cancer cells, potentially curing myeloma.

Risks
- Graft-Versus-Host Disease (GVHD):
- Donor cells attack the recipient's tissues.
- Ranges from mild to life-threatening.
- Acute GVHD requires powerful immunosuppressants like corticosteroids.
- Chronic GVHD can improve overall survival in milder cases.

Hospitalization and Recovery
- Hospital Stay:
- Typically 2-3 weeks for recovery.
- Outpatient Option:
- 30-40% undergo outpatient transplants with daily monitoring.
- Post-Transplant Care:
- Antibiotics, antiviral, and antifungal medications to prevent infections.
- Possible transfusions of red blood cells or platelets.

Considerations
- Side Effects:
- Significant risk of severe, life-threatening side effects.
- Eligibility:
- Often considered after an autologous transplant has failed.

Research and Improvements
- Ongoing Studies:
- New transplant regimens and improved treatments for side effects are being researched to make allogeneic transplants safer.

For more detailed information, you can visit the source: [Allogeneic (donor) stem cell transplant for Myeloma | MyMyelomaTeam](https://www.mymyelomateam.com/treatments/alloge...).

July 15, 2024

Related content

View All

Can Anyone Tell Me How Long They Were In The Hospital For Stem Cell Transplant??

A MyMyelomaTeam Member asked a question 💭
Southern New Jersey

Stem Cell Treatment

A MyMyelomaTeam Member asked a question 💭
Cape Town, ZA

Allogeneic Transplants Vs Stem Cell Transplants

A MyMyelomaTeam Member asked a question 💭
Stone Mountain, GA

Already a Member? Log in